"Neo-branched" human immunodeficiency virus antibody Western ink dot method 2.2 test reagent
Taiwan·Risk Class 3·MP BIOMEDICALS ASIA PACIFIC PTE. LTD.·Registered Aug 16, 2012 – Apr 07, 2014Cancelled- Analysis ID
- 0c60f1c32c1bea4537d9118bd3aded83
- Customs Code
- DHA00602384706
- Manufacturer
- MP BIOMEDICALS ASIA PACIFIC PTE. LTD.
- Manufacturer Country
- Singapore
- Authorized Representative
- NEW SCIENTIFIC EQUIPMENT CO., LTD.
- Intended Use
- Western ink dot testing for HIV-1 and HIV-2 antibodies in human serum or plasma can be used as a confirmation reagent for HIV-1, and HIV-2 positive patients should be confirmed with other reagents.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4020 Analysis of specific tests
- Import Information
- import
- Registration Date
- Aug 16, 2012
- Expiry Date
- Apr 07, 2014
- Cancellation Date
- Nov 15, 2016
- Status
- Logged out
- Reason
- 未展延而逾期者
Access comprehensive regulatory information for "Neo-branched" human immunodeficiency virus antibody Western ink dot method 2.2 test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 0c60f1c32c1bea4537d9118bd3aded83 and manufactured by MP BIOMEDICALS ASIA PACIFIC PTE. LTD.. The authorized representative in Taiwan is NEW SCIENTIFIC EQUIPMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.